Skip to main content

Advertisement

Log in

Interval Breast Cancer Epidemiology, Radiology and Biological Characteristics

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

When mammography screening programs are fully implemented, interval cancers comprise a substantial proportion of incident breast cancers. Interval cancers may have been overlooked at the last mammography examination or become apparent because they grew so rapidly that the detectable preclinical phase (sojourn time) was shorter than the screening interval. This overview describes the epidemiology, radiological and biological characteristics and time of diagnosis of interval breast cancers in population of mammography screening. Our team retrospectively collected data of symptomatic patients who presented to the West Hertfordshire Trust Breast Unit during the period from 1st of October 2016 until the 30th of September 2017 and identified any interval cancers (screening imaging 40 months prior). Imaging included two-view digital mammogram as well as ultrasound. The total number of cancers diagnosed during this period was 335 patients of which a total of 49 patients (14.6%) were interval cancers, with an average age of 62.42 years; 48 patients (97.9%) had new cancers while one patient (2.1%) had recurrent disease, and 2 patients (4%) had metastatic disease.

Average tumour size was 26.79 mm (range 81 mm); 37 patients (75. 5%) had IDC with or without other pathology while average tumour grade was grade 2. Our review demonstrated that interval cancers are more common with invasive high-grade disease; multicentre further studies including larger numbers will be very informative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

Bc:

breast cancer

NHSBSP:

NHS Breast Screening Program

DOA:

disclosure of audit

DOC:

duty of candour

MCC:

microcalcification

IDC:

invasive ductal carcinoma

ILC:

invasive lobular carcinoma

DCIS:

ductal carcinoma in situ

PLCIS:

pleomorphic lobular carcinoma in situ

LVI:

lymphovascular invasion

HR:

hormone receptors

SLNB:

sentinel lymph node biopsy

ALNC:

axillary lymph node clearance

WLE:

wide local excision

QA:

quality assurance

References

  1. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012. Int J Cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210

    Article  CAS  PubMed  Google Scholar 

  2. Bulliard JL, Sasieni P, Klabunde C, De Landtsheer JP, Yankaskas BC, Fracheboud J (2006) Methodological issues in international comparison of interval breast cancers. Int J Cancer 119:1158–1163

    Article  CAS  PubMed  Google Scholar 

  3. Warren R, Duffy S (2000) Interval cancers as an indicator of performance in breast screening. Breast Cancer 7:9–18

    Article  CAS  PubMed  Google Scholar 

  4. Houssami N, Irwig L, Ciatto S (2006) Radiological surveillance of interval breast cancers in screening programmes. Lancet Oncol 7:259–265. https://doi.org/10.1016/S1470-2045(06)70617-9

    Article  PubMed  Google Scholar 

  5. Bucchi L et al (2008) Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts. J Med Screen 15:30–35. https://doi.org/10.1258/jms.2008.007016

    Article  PubMed  Google Scholar 

  6. Andersen SB, Tornberg S, Lynge E, Von Euler-Chelpin M, Njor SH (2014) A simple way to measure the burden of interval cancers in breast cancer screening. BMC Cancer 14:782. https://doi.org/10.1186/1471-2407-14-782

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lowery JT, Byers T, Hokanson JE, Kittelson J, Lewin J, Risendal B, Singh M, Mouchawar J (2011) Complementary approaches to assessing risk factors for interval breast cancer. Cancer Causes Control 22:23–31. https://doi.org/10.1007/s10552-010-9663-x

    Article  PubMed  Google Scholar 

  8. Chiarelli AM et al (2006) Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection. Cancer Epidemiol Biomark Prev 15:1856–1862. https://doi.org/10.1158/1055-9965.EPI-06-0290

    Article  CAS  Google Scholar 

  9. Blanch J, Sala M, Ibáñez J, Domingo L, Fernandez B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Rué M, Salas D, for the INCA Study Group (2014) Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme. PLoS One 9:e110207. https://doi.org/10.1371/journal.pone.0110207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Boyd NF, Huszti E, Melnichouk O, Martin LJ, Hislop G, Chiarelli A, Yaffe MJ, Minkin S (2014) Mammographic features associated with interval breast cancers in screening programs. Breast Cancer Res 16:417. https://doi.org/10.1186/s13058-014-0417-7

    Article  PubMed  PubMed Central  Google Scholar 

  11. NHS Breast Screening Programme Reporting, classification and monitoring of interval cancers and cancers following previous assessment August 2017

  12. Taylor K, Britton P, O'Keeffe S, Wallis MG (2011) Quantification of the UK 5-point breast imaging classification and mapping to BI-RADS to facilitate comparison with international literature. Br J Radiol 84(1007):1005–1010. https://doi.org/10.1259/bjr/48490964

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE et al (2005) A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumours. Cancer Epidemiol BiomarkersPrev 14:1108–1112

    Article  CAS  Google Scholar 

  14. Sihto H, Lundin J, Lehtimäki T (2008) Molecular subtypes of breast cancer detected in mammography screening and outside of screening. Clin Cancer Res 14:4103–4110

    Article  CAS  PubMed  Google Scholar 

  15. Kalager M, Tamimi RM, Bretthauer M, Adami H-O (2012) Prognosis in women with interval breast cancer: population based observational cohort study. BMJ 345. https://doi.org/10.1136/bmj.e7536

  16. Dibden A et al (2014) Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme. Br J Cancer 110:560–564. https://doi.org/10.1038/bjc.2013.778

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank other radiologists in the Breast Unit Radiology Department for reporting mammograms and ultrasound scans.

Author information

Authors and Affiliations

Authors

Contributions

All authors were responsible for the ongoing patient’s care of the patient in the hospital, data collection, literature research and drafting the manuscript. SN and NJ were involved in patient’s diagnostics. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sherif Monib.

Ethics declarations

Competing Interests

The authors declare that they have no competing interests.

Ethical Approval

No ethical approval was needed for this study as it is a retrospective analysis of standard practice.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Monib, S., Narula, S. & Breunung-Joshi, N. Interval Breast Cancer Epidemiology, Radiology and Biological Characteristics. Indian J Surg 83 (Suppl 2), 328–332 (2021). https://doi.org/10.1007/s12262-019-01955-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-019-01955-8

Keywords

Navigation